search
Back to results

Interaction of Apelin and Angiotensin in the Human Forearm Circulation

Primary Purpose

Heart Disease, Vasodilation

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Angiotensin II
Noradrenaline infusion
Sponsored by
University of Edinburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Heart Disease focused on measuring Renin angiotensin system, Apelin, Vasodilatation, Heart disease, Vascular biology

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • > 18 years old
  • Healthy volunteers

Exclusion Criteria:

  • Lack of informed consent
  • Age < 18 years,
  • Current involvement in other research studies,
  • Systolic blood pressure >190 mmHg or <100 mmHg
  • Malignant arrhythmias
  • Renal or hepatic failure
  • Haemodynamically significant aortic stenosis
  • Severe or significant co morbidity
  • Women of childbearing potential.
  • Any regular medication

    • Previous history of any cardiovascular disease

Sites / Locations

  • Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Infusion of apelin

Sodium nitroprusside infusion

Arm Description

Using forearm venous occlusion plethysmography apelin will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.

Using forearm venous occlusion plethysmography sodium nitroprusside will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.

Outcomes

Primary Outcome Measures

Change in angiotensin II mediated vasoconstriction

Secondary Outcome Measures

Changes in relevant neurohumoral hormones in response to apelin infusion

Full Information

First Posted
May 13, 2009
Last Updated
August 9, 2010
Sponsor
University of Edinburgh
search

1. Study Identification

Unique Protocol Identification Number
NCT00901745
Brief Title
Interaction of Apelin and Angiotensin in the Human Forearm Circulation
Official Title
Investigating the Interaction of Apelin and Angiotensin II Peripheral Resistance Vessels in Vivo in Man
Study Type
Interventional

2. Study Status

Record Verification Date
May 2009
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
April 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Edinburgh

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease. Apelin has the ability to cause blood vessels to relax, increasing their diameter and hence blood flow down the blood vessel. The researchers wish to investigate the hypothesis that an infusion of apelin will reduce the effects of angiotensin II, which is know to reduce the diameter of blood vessels.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Disease, Vasodilation
Keywords
Renin angiotensin system, Apelin, Vasodilatation, Heart disease, Vascular biology

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Infusion of apelin
Arm Type
Experimental
Arm Description
Using forearm venous occlusion plethysmography apelin will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
Arm Title
Sodium nitroprusside infusion
Arm Type
Active Comparator
Arm Description
Using forearm venous occlusion plethysmography sodium nitroprusside will be infused to cause reduction in forearm blood flow. Infusion of angiotensin II and noradrenaline will given and vasoconstriction will be assessed. Blood samples for the infused arm and contra-lateral arm will be taken at regular time points to assess local and systemic changes in relevant hormones.
Intervention Type
Drug
Intervention Name(s)
Angiotensin II
Intervention Description
Infusion of up to 30picmol/ml angiotensin II will be infused and respondent vasoconstriction assessed.
Intervention Type
Drug
Intervention Name(s)
Noradrenaline infusion
Intervention Description
Infusion of up to 480 picomol/ml of noradrenaline will be infused.
Primary Outcome Measure Information:
Title
Change in angiotensin II mediated vasoconstriction
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Changes in relevant neurohumoral hormones in response to apelin infusion
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: > 18 years old Healthy volunteers Exclusion Criteria: Lack of informed consent Age < 18 years, Current involvement in other research studies, Systolic blood pressure >190 mmHg or <100 mmHg Malignant arrhythmias Renal or hepatic failure Haemodynamically significant aortic stenosis Severe or significant co morbidity Women of childbearing potential. Any regular medication Previous history of any cardiovascular disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gareth D Barnes, MBChB
Organizational Affiliation
University of Edinburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc
City
Edinburgh
ZIP/Postal Code
EH16 4SA
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Interaction of Apelin and Angiotensin in the Human Forearm Circulation

We'll reach out to this number within 24 hrs